The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications.

The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications.
复制标题

Kappa 阿片类药物系统在共病疼痛和精神疾病中的作用:功能和意义

DOI:
10.3389/fnins.2021.642493
复制
发表时间:
2021
影响因子:
4.3
通讯作者:
Liu C
Liu C
中科院分区:
医学2区
文献类型:
--
作者:
Ji MJ;Yang J;Gao ZQ;Zhang L;Liu C

文献摘要

参考文献

被引文献

相似文献

疼痛和精神疾病,如焦虑和抑郁,都会显著影响患者的生活质量。这两者也有很强的病理联系:慢性疼痛引起的负面影响驱动精神疾病的脆弱性,而患有共病精神疾病的患者往往会经历加剧的疼痛。然而,负责疼痛和精神疾病的共病的机制仍不清楚。已经确定kappa阿片系统有助于抑郁和烦躁状态。慢性疼痛的新兴研究揭示了κ阿片系统在疼痛处理中的作用和机制,特别是在情感的相关病理改变中。在这里,我们讨论了关键的发现和总结的化合物作用于κ阿片系统,是潜在的候选人的治疗策略,对共病疼痛和精神疾病。
Both pain and psychiatric disorders, such as anxiety and depression, significantly impact quality of life for the sufferer. The two also share a strong pathological link: chronic pain-induced negative affect drives vulnerability to psychiatric disorders, while patients with comorbid psychiatric disorders tend to experience exacerbated pain. However, the mechanisms responsible for the comorbidity of pain and psychiatric disorders remain unclear. It is well established that the kappa opioid system contributes to depressive and dysphoric states. Emerging studies of chronic pain have revealed the role and mechanisms of the kappa opioid system in pain processing and, in particular, in the associated pathological alteration of affection. Here, we discuss the key findings and summarize compounds acting on the kappa opioid system that are potential candidates for therapeutic strategies against comorbid pain and psychiatric disorders.
重复的游泳应力诱导阿片类阿片类药物介导的细胞外信号调节激酶1/2的激活。
DOI: 10.1097/wnr.0b013e32830dd655
发表时间: 2008-09-17
期刊: Neuroreport
影响因子: 1.7
作者:
Bruchas MR;Xu M;Chavkin C
通讯作者: Chavkin C
DOI: 10.3389/fphar.2014.00253
发表时间: 2014
影响因子: 5.6
作者:
Cahill CM;Taylor AM;Cook C;Ong E;Morón JA;Evans CJ
通讯作者: Evans CJ
DOI: 10.1016/0143-4179(85)90053-8
发表时间: 1985-01-01
期刊: NEUROPEPTIDES
影响因子: 2.9
作者:
FALLON, JH;LESLIE, FM;CONE, RI
通讯作者: CONE, RI
DOI: 10.1007/s00213-017-4637-2
发表时间: 2017-08
期刊: Psychopharmacology
影响因子: 3.4
作者:
Ewald AWM;Bosch PJ;Culverhouse A;Crowley RS;Neuenswander B;Prisinzano TE;Kivell BM
通讯作者: Kivell BM
DOI: 10.1124/jpet.108.142570
发表时间: 2008-12-01
影响因子: 3.5
作者:
Gardell, Luis R.;Ma, Jian-Nong;Burstein, Ethan S.
通讯作者: Burstein, Ethan S.